Gender	Female
Education and Training	MD, Columbia University College of Physicians and Surgeons
	BA, Barnard College
	Fellowship, Mount Sinai Medical Center
	Fellowship, Columbia Presbyterian Medical Center
	Residency, Columbia Presbyterian Medical Center
	Internship, Beth Israel Hospital
Awards	1988 Alpha Omega Alpha
	1988 The Harry S. Altman Prize in Pediatrics
	1983 Phi Beta Kappa
	1980 The Governor's Scholarship for Academic Excellence
	1979 The Governor's Scholarship for Academic Excellence

Dr. Kim -Schluger's expertise is the management of liver transplant recipients, as well as on the natural course and treatment of hepatitis C. Among her research efforts have been studies that named to identify different treatment options for patients with hepatitis C virus infection; to better understand the course of hepatitis C after liver transplantation and to determine the best immunosuppressive drug regimens for liver transplant recipients. Dr. Kim-Schluger also has a special interest in the controversial issues and ethical dilemmas of organ allocation.

Education and Training	MD, Columbia University College of Physicians and Surgeons
	BA, Barnard College
	Fellowship, Mount Sinai Medical Center
	Fellowship, Columbia Presbyterian Medical Center
	Residency, Columbia Presbyterian Medical Center
	Internship, Beth Israel Hospital

Kim-schluger H, Rotterdam H, Lebwohl O. Gastrointestinal hemorrhage from a Brunner's gland hamartoma. Am J Gastroenterology 1995; 21(2): 584-588.

Gurkan A, Emre S, Foshbein TM, Brady L, Millis M, Birnbaum A, Kim-schluger H, Sheiner PA. Unsuspected bile duct paucity in donors for living-related liver transplantation: two case reports. Transplantation 1999; 67: 416-418.

Guy SR, Magliocca JF, McDonough P, Emre S, Kim-schluger H, Sheiner PA, Fishbein TM, Schwartz ME, Miller CM. . Transmission of factor VII deficiency through liver transplantation. Transplant Int 1999; 12: 278-280.

Emre S, Schwartz ME, Shneider B, Hojsak J, Kim-schluger H, Fishbein TM, Guy SR, Sheiner PA, LeLeiko NS, Birnbaum A, Suchy FJ, Miller CM. Living related liver transplantation for acute liver failure in children. Transpl Surg 1999;: 161-165.

Kim-schluger H, Emre S, Guy SR, Sheiner PA, Fishbein TM, Schwartz ME, Miller CM. Safe transplantation of blood type A2 livers to blood type O recipients. Transplantation 1999; 67: 1071-1073.

Sheiner PA, Magliocca JF, Bodian CA, Kim-schluger H, Altaca G, Guarrera JV, Emre S, Fishbein T, Guy SR, Schwartz ME, Miller CM. Long-term medical complications in patients surviving [greater than or equal to] 5 years after liver transplant. Transplantation 2000; 69: 781-789.

Sheiner PA, Magliocca JF, Bodian CA, Kim-schluger H, Altaca G, Guarrera JV, Emre S, Fishbein TM, Guy SR, Schwartz ME, Miller CM. . Long-term medical complications in patients surviving 5 years after liver transplant. Transplantation 2000; 69: 781-789.

Emre S, Genyk Y, Kim-schluger H, Fishbein T, Guy SR, Sheiner P, Schwartz ME, Miller CM. Treatment of tacrolimus related adverse effects by conversion to cyclosporine in \tliver transplant recipients. Transplant International 2000;.

Brodsky N, Jaffe DL, Kim-Schluger L, Bodenheimer HC, Bach N. Decompensated Liver Disease associated with Hereditary Hemorrhagic Telangiectasia.;.